As­traZeneca throws a mon­key wrench in new GSK CEO’s first hir­ing de­ci­sion, su­ing Luke Miels

Back at the be­gin­ning of this year, one of Em­ma Walm­s­ley’s first moves as in­com­ing CEO of Glax­o­SmithK­line was to poach Luke Miels from As­traZeneca to head up the glob­al phar­ma­ceu­ti­cals busi­ness. Miels’ ex­pe­ri­ence in phar­ma and his ear­li­er role man­ag­ing the port­fo­lio and strat­e­gy at As­traZeneca, she said, gave him in­sights on R&D and the in­dus­try that would make him unique­ly suit­ed to the job.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER